InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
5
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-21.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Buchi J Kevin, Director. Insider active across 5 companies, notably Ziopharm Oncology INC. Aggregated, 18 filings have been logged. Breakdown: 5 buys · 0 sell. Total volume traded: €26k. History available since 4 March 2021. The latest transaction was filed on 11 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Buchi J Kevin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
168,573 shares@ US$17.18Class A Common StockSEC:0001628280-26-056752:0
51,813 sharesCommon StockSEC:0001193125-26-290586:0
40,258 sharesClass A Common StockSEC:0001628280-25-024004:0
103,626 shares0Common StockSEC:0001062993-25-005393:0
262,072 shares0Class A Common StockSEC:0001628280-25-012344:0
51,813 shares@ US$3.86100.0% of flowCommon StockSEC:0001062993-25-004077:0
76,453 sharesClass A Common StockSEC:0001628280-24-023247:0
51,813 sharesCommon StockSEC:0000950170-23-042536:0
Canonical exit: 9 Nov 2023 (T+90)
21,858 shares@ US$0.287522.5% of flowCommon StockSEC:0001615594-23-000047:0
Canonical exit: 7 Sept 2023 (T+90)
25,000 shares@ US$0.29626.4% of flowCommon StockSEC:0001615594-23-000046:0
Canonical exit: 6 Sept 2023 (T+90)
32,534 shares@ US$0.274331.6% of flowCommon StockSEC:0001615594-23-000033:0
Canonical exit: 14 Aug 2023 (T+90)
23,440 shares@ US$0.235219.5% of flowCommon StockSEC:0001615594-23-000032:0
Canonical exit: 10 Aug 2023 (T+90)
80,128 sharesClass A Common StockSEC:0001209191-23-028734:0
35,406 sharesClass A Common StockSEC:0001209191-22-028155:0
4,666 shares@ US$38.25100.0% of flowCommon StockSEC:0001399529-21-000195:0
4,666 sharesCommon StockSEC:0001399529-21-000106:0
46,218 sharesClass A Common StockSEC:0001209191-21-030806:0
4,167 shares0Common StockSEC:0001209191-21-030738:0
18 of 18 declarations
About Buchi J Kevin
BUCHI J KEVIN is a Director of Amneal Pharmaceuticals, Inc., Benitec Biopharma Inc., Ampio Pharmaceuticals, Inc., Dicerna Pharmaceuticals Inc and Ziopharm Oncology INC. He has 17 filings in total. Across the sampled recent filings, his buys total EUR 25956, his sells total EUR 0, the modal transaction nature is Levée d'options, and the date range runs from 2021-05-06 to 2026-06-30.
